Related Experiment Videos
[Heart failure in amyloidosis--a rare but treatable disease]
Monica Ohlsson1, Anders Oldfors, Per Hallgren
1Göteborgs universitet.
Insights
Cardiac amyloidosis, a rare cause of heart failure, requires consideration in patients without ischemic heart disease. Early diagnosis of this multisystem disease is crucial for effective treatment and improved prognosis.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Cardiac amyloidosis is a rare condition that can mimic other forms of heart failure.
- It is essential to consider cardiac amyloidosis in patients presenting with congestive heart failure without evidence of ischemic heart disease.
Observation:
- Diagnostic clues include increased ventricular wall thickness and normal chamber size on echocardiography.
- Low voltage on electrocardiogram and evidence of multisystem involvement suggest the diagnosis.
Findings:
- Common amyloid protein types include AA, AL, and transthyretin amyloidosis.
- Clinical manifestations vary based on the underlying cause and organs affected by amyloid infiltration.
Implications:
- Accurate typing of amyloid protein is critical as prognosis and treatment strategies differ significantly.
- Early diagnosis and targeted therapies can modify the course of these life-threatening systemic amyloidoses.
Abstract:
Cardiac amyloidosis is rare, but should be considered in the differential diagnosis of any patient with congestive heart failure who does not have evidence of ischemic heart disease. The diagnosis is more likely in patients with increased wall thickness and normal chamber size on echocardiogram, low voltage on the electrocardiogram, and evidence suggesting a multisystem disease. Amyloid proteins are varied; the most common are AA, AL and transthyretin. The clinical features differ and are largely determined by the underlying disease responsible for the amyloid infiltration and of the organs involved. The specific type of protein must be determined as the prognosis and treatment vary among the different types of amyloidoses. Systemic amyloidoses are life-threatening diseases but making an early diagnosis in connection with today's more specific treatment may modify the course of the disease.